The effect of gabapentin on Dysgeusia after ear surgery

Prevalence of Dysgeusia After Surgical Treatment of Chronic Otitis Media and Evaluation of Therapeutic Effect of Gabapentin

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200525047566N1

Enrollment

171

Registered

2021-08-08

Start date

2020-08-21

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysgeusia. Other disturbances of smell and taste

Interventions

Intervention 1: Intervention group: Patients with disgusia receive a daily dose of 600 mg of gabapentin capsules (Razak Pharmaceutical Company) for 3 months. Intervention 2: Control group: Patients wi

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who have undergone surgery to treat a chronic otitis media are questioned for the complication of Dysgeusia.

Exclusion criteria

Exclusion criteria: history of systemic diseases central and peripheral neurological diseases psychiatric illness metabolic disease history of Dysgeusia

Design outcomes

Primary

Measure	Time frame
The amount of taste. Timepoint: After surgery and 3 months after treatment. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Esmaeili

Shahid Beheshti University of Medical Sciences

arash.esmaeili@gmail.com+98 21 4422 3777

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026